William R Jellison bought $463K of Medtronic (MDT)
Executed Aug 22 2025, disclosed Aug 25 2025, 3 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 25 2025), the stock returned +2.4% (delay-adjusted); from the execution session (Aug 22 2025), +3.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
William R Jellison (Director) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in MASI. Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and +2.4% from disclosure (delay-adjusted; derived). The largest single filing was $463K of MDT (5,000 sh across 2 lots, as filed), executed Aug 22 2025.
Healthcare · Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→